EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC-ND 4.0

Use of GS-441524 in the Therapeutic Managemente os Feline Infectious Peritonitis (PIF): a systematic review os the literature

Tatiana Michelle Dias Custódio da Cruz, Renata Isabel Zimmermann, Wanessa Ferreira Boabaid, Tayná Padilha Basqueroto Antunes, Mariana Moreira Mendonça, Deborah Goulart Menegaz, Andryw Gomes Amorim, Luciano Diniz Dos Santos, Maria Raquel Silva

Brazilian Journal of One Health · 16.07.2026 · 3 (3) · 162-174

DOI: 10.70164/bjoh.v3i3.284 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Brazilian Journal of One Health, online erschienen am 16.07.2026. Verfasst von Tatiana Michelle Dias Custódio da Cruz und 8 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Feline coronavirus (FCoV) is a highly transmissible viral agent capable of infecting domestic and wild felids. According to its pathogenic characteristics, FCoV comprises two distinct biotypes: feline enteric coronavirus (FECV) and feline infectious peritonitis virus (FIPV), the latter being responsible for the development of feline infectious peritonitis (FIP), a severe and frequently fatal disease. Although the mechanisms underlying this process have not yet been fully elucidated, certain genetic alterations in the viral genome are believed to favor the transformation of FECV into FIPV. Furthermore, host immune response characteristics exert a significant influence on disease onset and progression. Clinically, FIP manifests as either the wet or effusive form or the dry or non-effusive form, both of which are associated with systemic abnormalities and an unfavorable prognosis, frequently resulting in the death of affected animals. Despite numerous studies aimed at elucidating its pathogenesis, feline infectious peritonitis remains a diagnostically challenging disease. In this context, the antiviral compound GS-441524 has demonstrated promising results, showing the ability to suppress viral replication and promote clinical remission after approximately 12 weeks of treatment. Diagnostic tools available to veterinarians include the Rivalta test, reverse transcription polymerase chain reaction (RT-PCR), direct immunofluorescence, immunoperoxidase assays, ante-mortem immunohistochemistry, and histopathological examination for post-mortem confirmation. Considering the immune-mediated component of the disease, supportive therapy has traditionally been based on modulation of the patient’s immune response through the administration of glucocorticoids for immunosuppressive purposes. The objective of this case report was to describe an alternative therapeutic approach using GS-441524 in a female Himalayan Persian cat diagnosed with feline infectious peritonitis at eight months of age. The therapeutic protocol consisted of the alternative administration of GS-441524 for 106 days, concomitantly with supportive treatment aimed at controlling clinical manifestations. Following completion of the 106 administrations of the compound, the patient exhibited laboratory parameters within normal reference ranges. Currently, two years after completion of treatment, the cat remains in complete remission, with no evidence of disease recurrence. Although further investigations are required, the results obtained with GS-441524 were promising, reinforcing the relevance of its regulated availability for use in veterinary medicine in Brazil.

Zitieren

APA

Cruz, T. M. D. C. D., Zimmermann, R. I., Boabaid, W. F., Antunes, T. P. B., Mendonça, M. M., Menegaz, D. G., Amorim, A. G., Santos, L. D. D., & Silva, M. R. (2026). Use of GS-441524 in the Therapeutic Managemente os Feline Infectious Peritonitis (PIF): a systematic review os the literature. Brazilian Journal of One Health, 3(3), 162-174. https://doi.org/10.70164/bjoh.v3i3.284

Vancouver

Cruz TMDCD, Zimmermann RI, Boabaid WF, Antunes TPB, Mendonça MM, Menegaz DG, et al. Use of GS-441524 in the Therapeutic Managemente os Feline Infectious Peritonitis (PIF): a systematic review os the literature. Brazilian Journal of One Health. 2026;3(3):162-174. doi:10.70164/bjoh.v3i3.284

BibTeX
@article{Cruz2026,
  author = {Cruz, Tatiana Michelle Dias Custódio da and Zimmermann, Renata Isabel and Boabaid, Wanessa Ferreira and Antunes, Tayná Padilha Basqueroto and Mendonça, Mariana Moreira and Menegaz, Deborah Goulart and Amorim, Andryw Gomes and Santos, Luciano Diniz Dos and Silva, Maria Raquel},
  title = {Use of GS-441524 in the Therapeutic Managemente os Feline Infectious Peritonitis (PIF): a systematic review os the literature},
  journal = {Brazilian Journal of One Health},
  year = {2026},
  volume = {3},
  number = {3},
  pages = {162--174},
  doi = {10.70164/bjoh.v3i3.284}
}
Kostenlos starten →